Lomitapide Mesylate is an oral lipid-lowering agent classified as a microsomal triglyceride transfer protein inhibitor used in the treatment of homozygous familial hypercholesterolemia. This category features… Read more
Lomitapide Mesylate is an oral lipid-lowering agent classified as a microsomal triglyceride transfer protein inhibitor used in the treatment of homozygous familial hypercholesterolemia. This category features high-quality reference standards for the active pharmaceutical ingredient, alongside a comprehensive range of pharmacopeial and non-pharmacopeial impurities and metabolites essential for rigorous quality control and impurity profiling. Laboratories rely on these compounds to support method validation and ensure the accuracy of analytical testing during drug development and manufacturing. Furthermore, stable isotope-labelled compounds are available for use as internal standards in quantitative bioanalytical methods, facilitating the precise measurement of drug concentrations in complex biological matrices. By utilizing these characterized reference materials, researchers can maintain strict compliance with regulatory standards and ensure the efficacy and safety of pharmaceutical products throughout their lifecycle.